- Home
- GRRR vs GNTA Comparison
GRRR vs GNTA Comparison
Compare GRRR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- GNTA
- Stock Information
- Founded
- GRRR 2001
- GNTA 2014
- Country
- GRRR United Kingdom
- GNTA Italy
- Employees
- GRRR N/A
- GNTA N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRRR Technology
- GNTA Health Care
- Exchange
- GRRR Nasdaq
- GNTA Nasdaq
- Market Cap
- GRRR 85.6M
- GNTA 96.0M
- IPO Year
- GRRR N/A
- GNTA 2021
- Fundamental
- Price
- GRRR $13.37
- GNTA $5.01
- Analyst Decision
- GRRR Buy
- GNTA Strong Buy
- Analyst Count
- GRRR 1
- GNTA 1
- Target Price
- GRRR $13.00
- GNTA $25.00
- AVG Volume (30 Days)
- GRRR 2.7M
- GNTA 5.8K
- Earning Date
- GRRR 01-03-2025
- GNTA 01-01-0001
- Dividend Yield
- GRRR N/A
- GNTA N/A
- EPS Growth
- GRRR N/A
- GNTA N/A
- EPS
- GRRR 2.28
- GNTA N/A
- Revenue
- GRRR $78,940,347.00
- GNTA N/A
- Revenue This Year
- GRRR $12.29
- GNTA N/A
- Revenue Next Year
- GRRR $21.40
- GNTA N/A
- P/E Ratio
- GRRR $5.87
- GNTA N/A
- Revenue Growth
- GRRR 424.97
- GNTA N/A
- 52 Week Low
- GRRR $2.09
- GNTA $2.20
- 52 Week High
- GRRR $14.37
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- GRRR 87.34
- GNTA 47.05
- Support Level
- GRRR $5.75
- GNTA $4.95
- Resistance Level
- GRRR $8.24
- GNTA $5.50
- Average True Range (ATR)
- GRRR 1.32
- GNTA 0.27
- MACD
- GRRR 0.60
- GNTA -0.01
- Stochastic Oscillator
- GRRR 88.40
- GNTA 45.56
About GRRR Gorilla Technology Group Inc. Ordinary shares
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.